Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer-Reference-Cited by-同舟云学术

Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer

Published:2008-06 Issue:6 Volume:19 Page:1135-1140
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Jeong J.,Jeung H.-C.,Rha S.Y.,Im C.K.,Shin S.J.,Ahn J.B.,Noh S.H.,Roh J.K.,Chung H.C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/6/1135/372378/mdn013.pdf

Reference25 articles.

1. Gastric cancer epidemiology and risk factors;Kelley;J Clin Epidemiol,2003

2. Review of second-line chemotherapy for advanced gastric adenocarcinoma;Wilson;Clin Oncol,2005

3. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer;Lacave;Am J Clin Oncol,1983

4. cis-Platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC Gastrointestinal Tract Cancer Cooperative Group;Lacave;Eur J Cancer,1985

5. An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer;Ohtsu;Jpn J Clin Oncol,1991

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observation of efficacy and prognosis of chemoradiotherapy with apatinib in combination with oxaliplatin+5-fluorouracil plus leucovorin in the gastric cancer in advanced stage;INT J RADIAT RES;2021

2. Efficacy and safety of high‐dose vs low‐dose leucovorin in patients with colorectal cancer: systematic review and meta‐analysis;Colorectal Disease;2019-07-17

3. Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan;Gastric Cancer;2018-04-16

4. Evolving treatments for advanced gastric cancer: appraisal of the survival trend;Expert Review of Anticancer Therapy;2016-05-23

5. Metastatic gastric cancer treatment: Second line and beyond;World Journal of Gastroenterology;2016